Send the following on WhatsApp
Continue to ChatTransoral Incisionless Fundoplication TIF 2.0 for Gastro-Esophageal Reflux Disease Using the Latest Iteration and Recently FDA Cleared EsophyX Z Report of First Worldwide Prospective Series of 10 patients Treated with EsophyX Z. https://www.sages.org/meetings/annual-meeting/abstracts-archive/transoral-incisionless-fundoplication-tif-2-0-for-gastro-esophageal-reflux-disease-using-the-latest-iteration-and-recently-fda-cleared-esophyx-z-report-of-first-worldwide-prospective-series-of-10-pati/